Jyoti Madhusoodanan is a freelance science writer based in Portland, Oregon.
Jyoti Madhusoodanan
From this contributor
Confusion at the crossroads of autism and hearing loss
Hearing difficulties and autism often overlap, exacerbating autism traits and complicating diagnoses.
Confusion at the crossroads of autism and hearing loss
Mutations in cancer gene tied to unique autism traits
Autistic people who carry mutations in a gene called PTEN have distinct behavioral and motor problems.
Mutations in cancer gene tied to unique autism traits
Analysis finds little evidence to support dietary interventions for autism
Special diets that eliminate certain foods or contain added supplements have minimal impact on autism traits, according to a review of 27 clinical trials.
Analysis finds little evidence to support dietary interventions for autism
Studies of autism treatments lack standard yardsticks
Clinical trials of autism treatments rarely use a consistent set of tools to measure efficacy, making it tough to compare the treatments.
Studies of autism treatments lack standard yardsticks
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.